widerrufen.
23.12 15:30
30 Min
Medical Frontiers: 2050-160
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge. (NHK WORLD-JPN)
23.12 15:30
30 Min
Medical Frontiers: 2050-160
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge. (NHK WORLD-JAPAN)
23.12 21:30
30 Min
Medical Frontiers: 2050-160
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge. (NHK WORLD-JPN)
23.12 21:30
30 Min
Medical Frontiers: 2050-160
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge. (NHK WORLD-JAPAN)
24.12 04:30
30 Min
Medical Frontiers: 2050-160
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge. (NHK WORLD-JPN)
24.12 04:30
30 Min
Medical Frontiers: 2050-160
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge. (NHK WORLD-JAPAN)
24.12 10:30
30 Min
Medical Frontiers: 2050-160
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge. (NHK WORLD-JPN)
24.12 10:30
30 Min
Medical Frontiers: 2050-160
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge. (NHK WORLD-JAPAN)
27.12 20:00
30 Min
Medical Frontiers: 2050-160
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge. (NHK WORLD-JPN)
27.12 20:00
30 Min
Medical Frontiers: 2050-160
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge. (NHK WORLD-JAPAN)